{"id":"W4386282157","doi":"10.1016/s2152-2650(23)00805-4","title":"POSTER: MM-161 Talquetamab + Daratumumab in Patients With Relapsed/Refractory Multiple Myeloma (RRMM): Updated TRIMM-2 Results","year":2023,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"ca_institutions":"Institute of Cancer Research; University of Calgary; Princess Margaret Cancer Centre","funders":"","keywords":"Daratumumab; Medicine; Refractory (planetary science); Multiple myeloma; Internal medicine; Lenalidomide; Oncology; Materials science; Metallurgy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003296872,0.000818543,0.001733913,0.0005123624,0.0003762146,0.001691941,0.0007728828,0.0009172916,0.00979115],"category_scores_gemma":[0.002687383,0.0003024629,0.002274931,0.0005537244,0.0002645658,0.0008638778,0.0006352094,0.002418463,0.00264059],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00116293,"about_ca_system_score_gemma":0.001297278,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001148269,"about_ca_topic_score_gemma":0.003349801,"domain_scores_codex":[0.9991779,0.0003129736,0.00009121316,0.00009425497,0.0002062881,0.0001173555],"domain_scores_gemma":[0.9987139,0.000439008,0.0002883633,0.00005750443,0.0002284028,0.0002729401],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.06787997,0.002090701,0.02135056,0.004881802,0.00637313,0.0002325288,0.000133206,0.001512175,0.004560674,0.0006685856,0.1489667,0.74135],"study_design_scores_gemma":[0.1031572,0.0517686,0.2711537,0.006172458,0.02699883,0.001967277,0.0003114483,0.002759183,0.009218955,0.002803693,0.5233659,0.0003227752],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.2884155,0.5635729,0.002053297,0.04598866,0.01490594,0.001689793,0.02171359,0.0008069825,0.0608533],"genre_scores_gemma":[0.6836663,0.1874001,0.00947367,0.04058339,0.01055909,0.001756403,0.04105995,0.0003225165,0.02517854],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.00979115,"threshold_uncertainty_score":0.0327546,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03119223362108285,"score_gpt":0.3182786297286981,"score_spread":0.2870863961076152,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}